Sustained hepatitis D virus-ribonucleic acid negativity after self-discontinuation of short-term bulevirtide therapy: a case report
Chronic hepatitis D virus (HDV) infection represents the most severe form of viral hepatitis and is associated with accelerated progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Bulevirtide (BLV), an entry inhibitor targeting the NTCP receptor, has recently emerged as the standard tr...